Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.08 |
mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.08 |
mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.08 |
mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.08 |
mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |
mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.08 | 0.09 |
mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.09 |
mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.09 |
mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |